We are live on
!
Find out more
AVM
Avalon Ventures Management Portfolio holdings
AUM
$14.2M
1-Year Est. Return
9.35%
This Fund
S&P 500
This Quarter
Est. Return
-25.23%
1 Year Est. Return
+9.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2M
AUM Growth
-$4.81M
(-25%)
Cap. Flow
+$244K
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Janux Therapeutics
JANX
|
+$244K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 90.83% |
| 2 | Healthcare | 9.17% |
Similar funds
RCMU
LM
KL
SI
TAC
TPC
DADR
PM
Avalon Ventures Management's Q3 2025 Portfolio in Review
As of Q3 2025, Avalon Ventures Management held 2 positions worth $14.2M, down 25% from $19M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 0%. Avalon Ventures Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 91% of assets, down from 95% a quarter earlier, followed by Healthcare.
- Avalon Ventures Management added most to Janux Therapeutics in Q3 2025, an estimated $244K increase.
- Avalon Ventures Management's ten largest holdings make up 100% of its $14.2M portfolio in Q3 2025.
- Avalon Ventures Management opened 0 new positions and closed 0 in Q3 2025.
- Avalon Ventures Management's portfolio value fell 25% quarter-over-quarter to $14.2M.
Based on Avalon Ventures Management's 13F filing for Q3 2025, filed 13 Nov 2025.